Cathepsin D was also found to be increased in human endometrium at the luteal phase, confirming its induction by progesterone, and in some invasive endometrial cancers
tamoxifen for gynecomastia While the therapeutic approaches to these subtypes focus on these respective receptors, the two pathways potentially converge, ultimately exerting their downstream effects on the cyclin D CDK4 6 pathway
